Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study

BACKGROUND: Risk factors for sepsis have not been assessed in patients receiving tumor necrosis factor-alpha inhibitors (TNFi) for immune-mediated inflammatory diseases (IMIDs) who are vulnerable to serious/hospitalized infections. METHODS: Data from 2003–2017 were obtained from Taiwan’s National He...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Wen-Cheng, Wang, Chen-Yu, Hsu, Bo-Chueh, Lin, Ching-Heng, Huang, Wen-Nan, Chen, Yi-Hsing, Wu, Chieh-Liang, Chen, Hsin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
When Rheumatology and Infectious Disease Come Together
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298427/
https://www.ncbi.nlm.nih.gov/pubmed/32595776
http://dx.doi.org/10.1177/1759720X20929208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298427/
https://www.ncbi.nlm.nih.gov/pubmed/32595776
http://dx.doi.org/10.1177/1759720X20929208

Ejemplares similares